Liver News and Research

RSS

Results of Phase 2a clinical trial of DR Cysteamine announced by Raptor Pharmaceutical

Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.

12 Oct 2009

Researchers find how KEAP1 tumor suppressor works

A tumor-suppressing protein snatches up an important cancer-promoting enzyme and tags it with molecules that condemn it to destruction, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports this week in the journal Molecular Cell.

12 Oct 2009

AACR to host its first Frontiers in Basic Cancer Research Meeting

The American Association for Cancer Research will host its first Frontiers in Basic Cancer Research Meeting in Boston from Oct. 8-11, 2009. The meeting is expected to draw nearly 500 leading scientists to present on high-profile topics like epigenetics, metastasis and systems biology, and create synergies among the many subfields of basic science.

12 Oct 2009

New technique may lead to more effective treatment for liver disease

A combination of bioengineering and medical research at the University of California, San Diego has led to a new discovery that could pave the way for more effective treatments for liver disease.

12 Oct 2009

Bad breath can be treated

All of us have experienced bad breath at some point. However, suffering from chronic bad breath, or halitosis, can be embarrassing and affect your self-esteem and relationships with family, friends and coworkers. The good news -- bad breath is often preventable and easily treated.

12 Oct 2009

Patients sue insurers for denying transplants

The Los Angeles Times has a two-part series on patients who have sued their insurers for denying potentially life-saving transplants.

9 Oct 2009

RXi Pharmaceuticals presents new preclinical data from its advanced RNAi therapeutic platform

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced the presentation of new preclinical data from its advanced RNAi therapeutic platform at its Annual Investor Event held in New York City on Monday, October 5, 2009.

9 Oct 2009

New York Governor participates in roundtable discussion on stem cell research

Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today. Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean of Einstein, and eight stem cell researchers discussed advances in medical therapies and treatments that Einstein scientists have been investigating since receiving more than $14 million in State funding for stem cell research.

9 Oct 2009

Clemson bioengineer designing new ways to target drugs

Clemson bioengineer Frank Alexis is designing new ways to target drugs and reduce the chances for side effects.

9 Oct 2009

CHFA awards two individuals for their contributions in natural and organic products industry

The natural health and organic products industry recognized the achievements of individuals committed to the growth of the sector in an awards presentation at the Canadian Health Food Association's (CHFA), Expo East, October 2-4, 2009.

8 Oct 2009

Insurer denies out-of-network liver transplants, lawsuit filed

A trial beginning next week targeting the nation's largest health insurer and its California subsidiary for allegedly automatically denying requests for out-of-network liver transplants will help shed light on the need for stronger health reform than is currently being considered, according to Consumer Watchdog. The group urged President Obama, White House representatives, and the national news media to follow the trial.

8 Oct 2009

Antidotes effective for treating acute liver failure patients in early stages of disease

The antidote for acute liver failure caused by acetaminophen poisoning also can treat acute liver failure due to most other causes if given before severe injury occurs, UT Southwestern Medical Center researchers and their colleagues at 21 other institutions have found.

8 Oct 2009

GlobeImmune to present an abstract of GI-5005 drug at AASLD's annual meeting

GlobeImmune Inc. today announced that a late breaking abstract related to GI-5005, its investigational hepatitis C virus (HCV) product candidate, has been accepted for presentation at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which will take place Oct. 31 through Nov. 4, 2009, in Boston, Mass.

7 Oct 2009

Combination of leukemia and breast cancer drugs inhibits cancer progression

When breast cancer spreads or metastasizes, it crashes through the body's protective fences. The disease becomes fatal when it travels outside the mammary ducts, enters the bloodstream and spreads to the bones, liver or brain.

7 Oct 2009

Measures taken by Memorial Blood Centers to stay prepared for the spread of H1N1 virus

Memorial Blood Centers today outlined steps the organization is taking to stay prepared for the spread of the H1N1 virus and to ensure a safe experience for blood donors and an ample blood supply for our communities.

7 Oct 2009

Hepatitis B Foundation calls for consistent monitoring and referral of HBV infected children

An expert panel of nationally recognized pediatric liver specialists convened by the Hepatitis B Foundation is calling for more consistent monitoring and referral of children chronically infected with the hepatitis B virus (HBV). The panel's recommendations for pediatricians and other primary care practitioners stress the need for routine monitoring of children with chronic HBV infections, and timely consultation with a pediatric liver specialist.

6 Oct 2009

FDA Advisory Committee approves Peginterferon alfa-2b for treating metastatic melanoma

Enzon Pharmaceuticals, Inc. today announced that the FDA Oncologic Drug Advisory Committee voted in favor of recommending approval of PEGINTRON® as a treatment in addition to surgery in patients with metastatic melanoma.

6 Oct 2009

New embolization technique offers better clinical outcomes in the treatment of liver cancer

The authors of a newly published paper in the September/October journal Vascular Disease Management conclude that the micro-bland embolization technique possible with Embozene(TM) Color-Advanced Microspheres leads to better clinical outcomes.

6 Oct 2009

Survival rates for multivisceral transplants increase with new treatment strategies

Data from the largest single-center experience of adult and pediatric intestinal and multivisceral transplantation show that survival rates have improved with the advent of innovative surgical techniques, novel immunosuppressive protocols and better post-operative management, said researchers at the Thomas E. Starzl Transplantation Institute in a study published in the October issue of Annals of Surgery.

6 Oct 2009

Bristol-Myers Squibb and AstraZeneca receive marketing authorisation for ONGLYZA in Europe

Bristol-Myers Squibb Company and AstraZeneca announced today that the European Commission has granted marketing authorisation for ONGLYZATM in the 27 countries of the European Union.

5 Oct 2009

Liver News and Research

Results of Phase 2a clinical trial of DR Cysteamine announced by Raptor Pharmaceutical

Researchers find how KEAP1 tumor suppressor works

AACR to host its first Frontiers in Basic Cancer Research Meeting

New technique may lead to more effective treatment for liver disease

Bad breath can be treated

Patients sue insurers for denying transplants

RXi Pharmaceuticals presents new preclinical data from its advanced RNAi therapeutic platform

New York Governor participates in roundtable discussion on stem cell research

Clemson bioengineer designing new ways to target drugs

CHFA awards two individuals for their contributions in natural and organic products industry

Insurer denies out-of-network liver transplants, lawsuit filed

Antidotes effective for treating acute liver failure patients in early stages of disease

GlobeImmune to present an abstract of GI-5005 drug at AASLD's annual meeting

Combination of leukemia and breast cancer drugs inhibits cancer progression

Measures taken by Memorial Blood Centers to stay prepared for the spread of H1N1 virus

Hepatitis B Foundation calls for consistent monitoring and referral of HBV infected children

FDA Advisory Committee approves Peginterferon alfa-2b for treating metastatic melanoma

New embolization technique offers better clinical outcomes in the treatment of liver cancer

Survival rates for multivisceral transplants increase with new treatment strategies

Bristol-Myers Squibb and AstraZeneca receive marketing authorisation for ONGLYZA in Europe

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News